Three notes:
- Verily’s existing clinical trial system, known as Baseline, has more than 500,000 people who are interested in participating in clinical research, according to an Aug. 17 news release. Baseline matches interested people with research opportunities that fit their profiles.
- SignalPath’s platform helps research sites improve costs while mitigating the complexities and time associated with trials. With Verily, SignalPath will provide clinical research sites with a portfolio of resources.
- SignalPath employees will join Verily at the time of closing. They will maintain their physical presence in Raleigh, N.C., increasing Verily’s geographic footprint with this new location in North Carolina, the news release said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
